Other Products

Food Ingredients and Chemical Product Materials

The food ingredients and chemical product materials business is handled by Sumitomo Dainippon Pharma subsidiary DSP Gokyo Food & Chemical Co., Ltd.
In the food ingredients and food additives business, the company develops and sells food ingredients and additives for use in manufacturing safe, high-quality foods. Products include polysaccharides, primarily GLYLOID® (tamarind seed gum), the first product of its kind successfully produced by us on an industrial scale; seasonings such as soup bouillon. We also run the information portal site aimed at maximizing the value of polysaccharides, our core products.
The chemical product materials business encompasses such products as active pharmaceutical ingredients, cosmetic materials, electronic chemicals, coatings and industrial chemicals. Leveraging Sumitomo Dainippon Pharma's technologies and know-how from the pharmaceuticals business, and through cooperation with domestic and overseas suppliers, we are expanding these business units to a wide range of customers. We will aim to expand this business as a company that integrates research, development and sales operations to continually create value that is recognized by all.


Animal Health Products

The animal health products business is conducted by Sumitomo Dainippon Pharma subsidiary DS Pharma Animal Health Co., Ltd.
The major products are veterinary medicinal products and therapeutic nutritional formulas for companion animals, primarily dogs and cats, as well as for livestock such as cattle, swine, poultry, horses and aquacultured fish.
In the companion animal market, its focus business segment, DS Pharma Animal Health sells various therapeutics, including VICTAS®, an antibacterial preparation, PRONAMID®, a canine gastroprokinetic agent for the improvement of gastrointestinal motility, ds PIMOHEART® for chronic canine heart failure, and OraStripTM, a test strip of halitosis as an indicator for canine oral health management.
For the livestock industries, DS Pharma Animal Health provides VICTAS® Soluble Powder 25%, a fluoroquinolone antibiotic for swine, URSO®, a bile acid product for cattle, EQVALAN® paste, an oral anthelmintic for horses, and other products. For the aquaculture industry, the company provides vaccines and other products including anesthetics for fish and crustaceans and synthetic antibacterial drugs, contributing to security and safety of food. In addition, the company deals in feed additives and mixed feeds for maintaining animal's health and improving productivity.
As a research and development based animal health company, we will continue our efforts to create high-quality products that deliver new value that support the well-being of animals and promote a blissful society where animals and people live together harmoniously.

DS Pharma Animal Health Co., Ltd.

Diagnostics and Research Materials

Sumitomo Dainippon Pharma subsidiary DS Pharma Biomedical Co., Ltd. conducts the diagnostics and research materials business.
In the diagnostics business, to help ensure accurate and timely treatment, the company develops and supplies point-of-care testing (POCT) products, such as diagnostics for infectious diseases like influenza and Streptococcus, and the H-FABP detecting reagent as diagnostics for acute myocardial infarction, as well as born and calcium metabolism markets and diagnostics for neuropsychiatric disorder. The company is also developing biomarkers as companion diagnostics, which are performed to predict the efficacy and/or side-effects of drugs before they are administered, and developing and selling highly-sensitive and advanced products by combining chemiluminescent/fluorescent equipment and special reagents.
In addition, DS Pharma Biomedical develops and supplies research materials that facilitate research related to medical care. It is focusing on creating new value by providing cells and culture media that can be applied in regenerative therapy using ES cells and iPS cells.
The company aims to contribute to drug discovery research through companion diagnostic biomarker developments and a new early-stage drug discovery assay system that applies cell culture techniques.

DS Pharma Biomedical Co., Ltd.